And you thought you could stop worrying about re-importation. Just a few days after it was killed off by senators negotiating their healthcare reform deal, it got a new lease on life from the White House. The Obama administration yesterday promised it would press forward with its proposal to…

Has Eli Lilly anointed CFO Derica Rice as heir-apparent to current CEO John Lechleiter ( photo )? Yes, we know Lechleiter has only been in the chief executive’s office for two years now. But as Dow Jones reports, Lechleiter just handed some big responsibilities to Rice, indicating that he’s…

Bristol-Myers Squibb said its stock-swap offer as part of its spinoff of Mead Johnson Nutrition attracted nearly twice as many shares as it can exchange, so holders who tendered at least 100 shares will get 53.8 percent swapped for Mead Johnson stock. Report

Original Source of BMS stockholders flock…

So, who’s more powerful in Washington: Tanning-bed companies or cosmetic-drug makers? The latter, of course–and the proof is in the pudding otherwise known as healthcare reform. The latest Senate legislation scrapped the so-called “Botax” of 5 percent on elective cosmetics procedures in favor of a 10 percent tax on…

Sanofi-Aventis continues its shopping spree with a $1.9 billion deal for the consumer healthcare group Chattem. Aided by the support of Chattem’s board, the French drugmaker will mount a tender offer for all of its stock at $93.50 per share. That’s a 34 percent premium over Friday’s closing price….

Big Pharma made this a big year for Indian drugmakers. As multinational companies sought ways to cut costs and grow revenues, they ramped up their outsourcing programs and partnerships–and that has helped push sales growth past 20 percent for India’s leading drugmakers, such as Ranbaxy Laboratories, Cipla, Dr Reddy’s…

Boehringer Ingelheim Pharmaceuticals, Inc. and Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) has approved SPIRIVA® HandiHaler® (tiotropium bromide inhalation powder) for the reduction of exacerbations in patients with chronic obstructive pulmonary disease (COPD).

Original Source of FDA Approves SPIRIVA® HandiHaler® for the Reduction of COPD Exacerbations…

GlaxoSmithKline is considering three U.K. sites for its first biopharmaceutical factory in the country,

Celgene is one step closer to getting its cancer drug Revlimid widely adopted as a maintenance treatment for multiple myeloma. Initial results from a new trial showed that it delayed disease progression in patients who had had stem cell transplants, Reuters reports. Currently the drug is FDA-approved for use…

The conflicts-of-interest police have turned their attention to the Centers for Disease Control and Prevention. The inspector general of the Department of Health and Human Services issued a report saying that CDC did a poor job of screening its medical experts for financial conflicts when it engaged them for…